Inventor
GUERRY PHILIPPE
CH19 patents
⚠️ This page may combine multiple inventors who share the name “GUERRY PHILIPPE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
10 patentsUS5239084AAug 24, 1993
Substituted aminoalkyl biphenyl compounds
HOFFMANN LA ROCHE40 citations92
US5177067AJan 5, 1993
Substituted aminoalkyl biphenyl compounds and method of treating fungal infections
HOFFMANN LA ROCHE33 citations92
US5106878AApr 21, 1992
Use of substituted aminoalkoxybenzene derivatives in the control or prevention of fungal infections
HOFFMANN LA ROCHE28 citations92
US7265125B2Sep 4, 2007
Neuropeptide Y antagonists
HOFFMANN LA ROCHE18 citations91
US5214046AMay 25, 1993
Substituted aminoalkoxybenzene anti-fungicidal compositions and use
HOFFMANN LA ROCHE12 citations74
US5137920AAug 11, 1992
Method of treating fungal infections
HOFFMANN LA ROCHE10 citations74
US5763450AJun 9, 1998
Substituted benzyl pyrimidines
HOFFMANN LA ROCHE9 citations71
US6114330ASep 5, 2000
Substituted 2,4-diaminopyrimidines
HOFFMANN LA ROCHE3 citations62
US5866583AFeb 2, 1999
Substituted 2,4-diaminopyrimidines
HOFFMANN LA ROCHE7 citations62
US6900226B2May 31, 2005
Neuropeptide Y antagonists
HOFFMANN LA ROCHE0 citations51
IDORSIA PHARMACEUTICALS LTD
5 patentsUS10202368B2Feb 12, 2019
CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations59
US9920010B2Mar 20, 2018
CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations58
US11306078B2Apr 19, 2022
Piperidine CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations57
US11339148B2May 24, 2022
Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
IDORSIA PHARMACEUTICALS LTD0 citations51
US10752620B2Aug 25, 2020
Piperdine CXCR7 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations47